bioRxivCancer BiologyPreprint
Single-Cell Analysis of Hyperthermic Intraperitoneal Chemotherapy Treated Tumors Reveals Distinct Cellular and Molecular Responses
M. P. Horowitz, Z. Alali, T. Alban, C. Hong, E. Esakov, T. H. Hwang, J. Lathia, C. M. Michener, R. DeBernardo, O. Reizes
Abstract
Hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a clinical regimen that prolongs overall survival for patients with advanced Epithelial Ovarian Cancer (EOC). However, the mechanism of action of HIPEC remains poorly understood. To provide insights into the rapid changes that accompany HIPEC, tumors from five patients with high grade serous ovarian cancer were harvested from the omentum at time of debulking and after 90 minutes of HIPEC treatment. Specimens were rapidly dissociated into single cells and processed for single cell RNA-seq. Unbiased clustering identified 19 cell clusters that were annotated based on cellular transcriptome signatures to identify the epithelial, stromal, T and B immune cells, macrophages, and natural killer cell populations. Hallmark pathway analysis revealed heat shock, metabolic reprogramming, inflammatory, and EMT pathway enrichment in distinct cell populations upon HIPEC treatment. Collectively, our findings provide the foundation for mechanistic studies focused on how HIPEC orchestrates the ovarian cancer tissue response.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Novel Non-Invasive Epithelial Ovarian Cancer Mouse Model Of Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Z. Alali, M. P. Horowitz, … O. Reizes·bioRxiv·May 16, 2021
- Short-term oxaliplatin exposure according to established hyperthermic intraperitoneal chemotherapy (HIPEC) protocols lacks effectiveness in vitro and ex vivo
M. W. Löffler, N. Seyfried, … S. Beckert·bioRxiv·Jul 31, 2019
- A senescence-like state is beneficial for ovarian cancer treatment
M. Skulimowski, L. Calvo Gonzalez, … F. Rodier·bioRxiv·Sep 30, 2023
- Single-cell RNA-seq analysis profiling characterizes differences in cell composition and physiology between normal tissue, treatment-naive, and cisplatin-treated ovarian cancer
F. Guo, Z. Yang, … A. Kaufmann·bioRxiv·Jan 2, 2024
- Tumor landscape of epithelial ovarian cancer highlights that EGR1 drives tumor invasion at single-cell resolution
Yuan-Fu Zhang, Shu Sun, … Qiuyan Guo·bioRxiv·Jul 26, 2022
- Tumor Cells Enriched for Interferon and Inflammatory Programs Pre-Exist in High Grade Serous Ovarian Cancer and are Proportionately Significantly Increased Post Chemotherapy
Boris J. N. Winterhoff, Nomeda Girnius, … Joan S. Brugge·bioRxiv·Jun 24, 2025